Market Overview
Congestive Heart Failure (CHF) refers to a condition where the heart is unable to pump blood effectively, leading to a variety of health complications. The market for CHF treatment devices is experiencing significant growth due to increasing incidences of heart disease, advancements in medical technology, and growing demand for effective heart failure management solutions. These devices range from implantable devices like pacemakers and defibrillators to ventricular assist devices (VADs) and wearable monitors.
